Invited Speakers:
|
|
Anton Beletskii, Ph.D., Cell Biologist, Molecular and Cell Biology Laboratory, General Electric Steven Charlton, Novartis Peter Fürst, Ph.D. (Keynote Speaker), Head Basel Screening Operation, Novartis Institutes for Biomedical Resarch Jon Hawkinson, Principal Scientist, Elan Pharmaceuticals Ron Johnson, Ph.D., NHGRI, NIH John Morin, Director HTS, Wyeth Research Jonathan O'Connell, Associate Director, Lead Discovery, Bristol-Myers Squibb Jefferson Paslay (Keynote Speaker), Vice President, Screening Sciences, Wyeth Research Matt Peters, AstraZeneca Pharmaceuticals Frank Stuhmeier, Ph.D., Senior Principle Scientist, Pfizer, Inc. Jun Xian, Assistant Director, Harvard University Dominique Perrin, Group Leader, Biochemical Pharmacology, Serono Pharmaceutical Research Institute Susan Pratt, Eli Lilly & Co. Laura DeForge, Ph.D., Senior Scientist, Genentech, Inc. Frederick Monsma, Director, New Lead Discovery, Schering-Plough Research Institute Michael Weber, Merck & Co. Karl Salzwedel, Head of High-Throughput Drug Discovery, Panacos Pharmaceuticals Tara Stauffer, Pharmacopeia Drug Discovery, Inc. Christopher Heise, Scientist II, Dept. of Discovery Biology, Neurocrine Biosciences Yaya Liu, Abbott Laboratories
|
|